Results: 1-4 |
Results: 4

Authors: Noone, PG Hamblett, N Accurso, F Aitken, ML Boyle, M Dovey, M Gibson, R Johnson, C Kellerman, D Konstan, MW Milgram, L Mundahl, J Retsch-Bogort, G Rodman, D Williams-Warren, J Wilmott, RW Zeitlin, P Ramsey, B
Citation: Pg. Noone et al., Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: Results of a phase I multi-center study, PEDIAT PULM, 32(2), 2001, pp. 122-128

Authors: Rosenfeld, M Emerson, J Williams-Warren, J Pepe, M Smith, A Montgomery, AB Ramsey, B
Citation: M. Rosenfeld et al., Defining a pulmonary exacerbation in cystic fibrosis, J PEDIAT, 139(3), 2001, pp. 359-365

Authors: Ramsey, BW Pepe, MS Quan, JM Otto, KL Montgomery, AB Williams-Warren, J Vasiljev-K, M Borowitz, D Bowman, CM Marshall, BC Marshall, S Smith, AL
Citation: Bw. Ramsey et al., Intermittent administration of inhaled tobramycin in patients with cystic fibrosis, N ENG J MED, 340(1), 1999, pp. 23-30

Authors: Smith, AL Doershuk, C Goldmann, D Gore, E Hilman, B Marks, M Moss, R Ramsey, B Redding, G Rubio, T Williams-Warren, J Wilmott, R Wilson, HD Yogev, R
Citation: Al. Smith et al., Comparison of a beta-lactam alone versus beta-lactam and an aminoglycosidefor pulmonary exacerbation in cystic fibrosis, J PEDIAT, 134(4), 1999, pp. 413-421
Risultati: 1-4 |